WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES

This group comprises agents for the treatment of hypotension. Respiratory stimulants are classified in R07AB.
Dihydroergotamine, which is used in the treatment of migraine as well as hypotension, is classified in N02CA - Ergot alkaloids.
Combinations with peripheral vasodilators, see C04 - Peripheral vasodilators.

This group includes various drugs used on different indications. The DDDs are therefore established individually for each substance (i.e. each ATC 5th level).


C01CA Adrenergic and dopaminergic agents

This group comprises sympathomimetics used in the treatment of hypotension. Etilefrin in combination with dihydroergotamine is classified in this group. Oral products of ephedrine are classified in R03CA.


    ATC code  Name  DDD  U Adm.R Note
    C01CA18 octopamine    

List of abbreviations

Last updated: 2020-12-17